Righetti P G, Conti M, Gelfi C
Department of Agricultural and Industrial Biotechnology, University of Verona, Italy.
J Chromatogr A. 1997 Apr 11;767(1-2):255-62. doi: 10.1016/s0021-9673(97)00011-3.
A novel method is described for monitoring complex formation between macromolecules, based on combined isoelectric focusing-electrophoresis in capillaries. The example studied is the binding of serum haptoglobin (Hp) to hemoglobin (Hb). A known amount of Hb is focused in a capillary in a pH 6-8 range (pI of Hb = 7.0) and thus kept temporarily "immobilized" in the electrophoretic chamber. Subsequently, increasing amounts of ligand (Hp) are loaded cathodically and allowed to sweep past the focused Hb zone. As the complex formed has a pI value well-outside the bounds of such a pH gradient (the 1:1 molar Hb-Hp complex has a pI of 5.5, the 1 to 1/2 molar Hp-Hb complex has a pI of 5.0) it escapes immobilization and moves past the detector window, where it is monitored and quantified. Since the detector is set at 416 nm, where only Hb absorbs, and since the molar extinction coefficient of Hb is well known, it is quite easy to calculate the molar amount of Hb bound to the complex. As an additional check, the amount of unreacted Hb can now be mobilized by disrupting the pH gradient and allowing this residual free Hb to also reach the detector and be quantified. The method is easy, fast, simple and fully automated and thus could represent a valid alternative to existing methods in clinical chemistry for quantifying the amount of Hp in human sera in pathological conditions, such as hemolytic anemias and transfusion reactions.
本文描述了一种基于毛细管中组合等电聚焦-电泳监测大分子间复合物形成的新方法。所研究的例子是血清结合珠蛋白(Hp)与血红蛋白(Hb)的结合。已知量的Hb在pH 6 - 8范围内(Hb的pI = 7.0)在毛细管中聚焦,从而暂时“固定”在电泳室中。随后,将越来越多的配体(Hp)从阴极加载,并使其扫过聚焦的Hb区。由于形成的复合物的pI值远超出这种pH梯度范围(1:1摩尔比的Hb - Hp复合物的pI为5.5,1:1/2摩尔比的Hp - Hb复合物的pI为5.0),它不会被固定,而是移动经过检测窗口,在那里被监测和定量。由于检测器设置在416 nm处,只有Hb在该波长吸收,并且Hb的摩尔消光系数是已知的,所以很容易计算与复合物结合的Hb的摩尔量。作为额外的检查,现在可以通过破坏pH梯度来移动未反应的Hb的量,使这种残留的游离Hb也到达检测器并进行定量。该方法简便、快速、简单且完全自动化,因此在临床化学中,对于诸如溶血性贫血和输血反应等病理状况下人体血清中Hp含量的定量,可能是现有方法的一种有效替代方法。